Characteristics, Comorbidities, and Outcomes in a Multicenter Registry of Patients With Human Immunodeficiency Virus and Coronavirus Disease 2019
Montgomery, Mary W
Antar, Annukka A R
Llibre, Josep M
Díaz-De Santiago, Alberto
Carlucci, Philip M
Zacharioudakis, Ioannis M
Wanjalla, Celestine N
Kratz, Ann Marie Porreca
Jones, Joyce L
Patel, Shital M
Koren, David E
Baddley, John W
Sax, Paul E
JournalClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
PublisherOxford University Press
MetadataShow full item record
AbstractBACKGROUND: People living with human immunodeficiency virus (HIV) may have numerous risk factors for acquiring coronavirus disease 2019 (COVID-19) and developing severe outcomes, but current data are conflicting. METHODS: Health-care providers enrolled consecutively, by nonrandom sampling, people living with HIV (PWH) with lab-confirmed COVID-19, diagnosed at their facilities between 1 April and 1 July 2020. Deidentified data were entered into an electronic Research Electronic Data Capture (REDCap) system. The primary endpoint was a severe outcome, defined as a composite endpoint of intensive care unit (ICU) admission, mechanical ventilation, or death. The secondary outcome was the need for hospitalization. RESULTS: There were 286 patients included; the mean age was 51.4 years (standard deviation, 14.4), 25.9% were female, and 75.4% were African American or Hispanic. Most patients (94.3%) were on antiretroviral therapy, 88.7% had HIV virologic suppression, and 80.8% had comorbidities. Within 30 days of testing positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), 164 (57.3%) patients were hospitalized, and 47 (16.5%) required ICU admission. Mortality rates were 9.4% (27/286) overall, 16.5% (27/164) among those hospitalized, and 51.5% (24/47) among those admitted to an ICU. The primary composite endpoint occurred in 17.5% (50/286) of all patients and 30.5% (50/164) of hospitalized patients. Older age, chronic lung disease, and hypertension were associated with severe outcomes. A lower CD4 count (<200 cells/mm3) was associated with the primary and secondary endpoints. There were no associations between the ART regimen or lack of viral suppression and the predefined outcomes. CONCLUSIONS: Severe clinical outcomes occurred commonly in PWH with COVID-19. The risks for poor outcomes were higher in those with comorbidities and lower CD4 cell counts, despite HIV viral suppression. CLINICAL TRIALS REGISTRATION: NCT04333953. © The Author(s) 2020.
Rights/Terms© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: firstname.lastname@example.org.
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/17092
- Clinical characteristics and outcomes of people living with HIV hospitalized with COVID-19: a nationwide experience.
- Authors: Ceballos ME, Ross P, Lasso M, Dominguez I, Puente M, Valenzuela P, Enberg M, Serri M, Muñoz R, Pinos Y, Silva M, Noguera M, Dominguez A, Zamora F, Chilean HIV/COVID-19 Study Group
- Issue date: 2021 Apr
- Clinical characteristics and outcomes of COVID-19 in people living with HIV in Belgium: A multicenter, retrospective cohort.
- Authors: Nasreddine R, Florence E, Moutschen M, Yombi JC, Goffard JC, Derdelinckx I, Lacor P, Vandekerckhove L, Messiaen P, Vandecasteele S, Delforge M, De Wit S, Belgian Research on AIDS and HIV Consortium (BREACH)
- Issue date: 2021 May
- Coronavirus Disease 2019 (COVID-19) Infection Among People With Human Immunodeficiency Virus in New York City: A Population-Level Analysis of Linked Surveillance Data.
- Authors: Braunstein SL, Lazar R, Wahnich A, Daskalakis DC, Blackstock OJ
- Issue date: 2021 Jun 15
- Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study.
- Authors: Nomah DK, Reyes-Urueña J, Díaz Y, Moreno S, Aceiton J, Bruguera A, Vivanco-Hidalgo RM, Llibre JM, Domingo P, Falcó V, Imaz A, Cortés C, Force L, Letang E, Vilaró I, Casabona J, Miro JM, PISCIS study group
- Issue date: 2021 Nov
- Clinical characteristics, comorbidities and outcomes among persons with HIV hospitalized with coronavirus disease 2019 in Atlanta, Georgia.
- Authors: Collins LF, Moran CA, Oliver NT, Moanna A, Lahiri CD, Colasanti JA, Kelley CF, Nguyen ML, Marconi VC, Armstrong WS, Ofotokun I, Sheth AN
- Issue date: 2020 Oct 1